Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
Product Images NDC 43598-115

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hbr (NDC 43598-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Guaifenesin 600 mg and Dextromethorphan Hydrobromide 30 mg Extended-Release Tablets by Dr. Reddy's Laboratories Inc. The box contains 20 tablets and highlights its use as an expectorant and cough suppressant with features like controlling cough, thinning and loosening mucus, and immediate and extended release. The label includes a 12-hour effectiveness indication and a comparison to Mucinex DM Extended-Release Bi-Layer Tablets.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Dr. Reddy's Guaifenesin 1200 mg and Dextromethorphan Hydrobromide 60 mg extended-release tablets. The label indicates the product is labeled as an expectorant and cough suppressant, with 7 extended-release tablets per package. It highlights maximum strength and 12-hour effectiveness.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.